Wildier, J.: search on Z-Library

The world's largest scientific articles store. 70,000,000+ articles for free.

Don't use scam websites

51

0139 Why 28% of ER-negative/PR-negative breast cancer (BC) patients did not get chemotherapy (CT)

O. Brouckaert, V. Van Belle, P. Berteloot, F. Amant, K. Leunen, T. Van Gorp, H. Wildiers, R. Paridaens, I. Vergote, P. Neven

Journal:

Year:

2009

Language:

english

File:

PDF, 51 KB

english, 2009

52

0192 Does the stellate ganglion block reduce severe hot flushes and sleep disturbances in breast cancer patients?

K. Haest, A. Kumar, K. Leunen, A. Smeets, F. Amant, H. Wildiers, R. Paridaens, E. Van Limbergen, W. Van den Bogaert, C. Weltens, I. Vergote, E. Vandermeersch, M. Christiaens, P. Neven, P. Berteloot

Journal:

Year:

2009

Language:

english

File:

PDF, 50 KB

english, 2009

53

0183 Progranulin (PC-derived growth factor) levels in serum do not predict response to neoadjuvant capecitabine (X), docetaxel (T) and trastuzumab (H) for patients (pts) with locally advanced breast cancer (LABC)

H. Wildiers, I. Buysschaert, A. Van Hootegem, A. Smeets, I. Vanden Bempt, P. Neven, P. Moerman, P. Schöffski, R. Paridaens, D. Lambrechts

Journal:

Year:

2009

Language:

english

File:

PDF, 63 KB

english, 2009

54

Phase I/II Pharmacokinetic Study of Pemetrexed and Epirubicin in Patients with Locally Advanced or Metastatic Breast Cancer

Robert Paridaens, Luc Dirix, Herlinde Dumez, Annemie Prové, Hans Wildiers, Ana Alvarez, Celia Tosello Oliveira, Jane Latz, Lorinda Simms, Allen Melemed

Journal:

Clinical Breast Cancer

Year:

2007

Language:

english

File:

PDF, 110 KB

english, 2007

55

Role of bone and kidney in tumor-induced hypercalcemia and its treatment with bisphosphonate and sodium chloride

Hubertus I.J. Harinck, Olav L.M. Bijvoet, AndréS.T. Plantingh, Jean-Jacques Body, Jan Willem F. Elte, Harm P. Sleeboom, Johan Wildiers, Jan P. Neijt

Journal:

The American Journal of Medicine

Year:

1987

Language:

english

File:

PDF, 1.12 MB

english, 1987

56

Mitoxantrone, 5-fluorouracil and leucovorin in metastatic breast cancer

J. Lemmens, P. Berteloot, J. Thomas, J. Wildiers, R. Paridaens

Journal:

European Journal of Cancer

Year:

1995

Language:

english

File:

PDF, 240 KB

english, 1995

57

48 Influence of concomitant radiotherapy on dose intensity of adjuvant CMF in patients with node-positive breast cancer

R.J. Paridaens, J. Lemmens, N. Devadder, E. Van Limbergen, W. Van den Bogaert, J. Thomas, J. Wildiers, M.R. Christiaens

Journal:

European Journal of Cancer

Year:

1995

Language:

english

File:

PDF, 164 KB

english, 1995

58

PP-8-1 Combined estroyen suppression and receptor (ER) blockade by buserelin (LHRH-A) and tamoxifen (TAM) in premenopausal metastatic breast cancer: Preliminary results of a 3-arm randomized study (EORTC 10881)

J.G.M. Klijn, C. Seynaeve, L. Beex, L. Mauriac, J. van Zijl, C. Veyret, J. Wildiers, J. Jassem, J. Burghouts, M. Becquart, M. Namer, M. Piccart, J. Garcia-Conde, F. Mignolet, G. Hoctin-Boes

Journal:

European Journal of Cancer

Year:

1996

Language:

english

File:

PDF, 182 KB

english, 1996

59

Taxanes in elderly breast cancer patients

Hans Wildiers, Robert Paridaens

Journal:

Cancer Treatment Reviews

Year:

2004

Language:

english

File:

PDF, 206 KB

english, 2004

60

Combretastatin A-4 phosphate enhances CPT-11 activity independently of the administration sequence

H. Wildiers, B. Ahmed, G. Guetens, G. De Boeck, E.A. de Bruijn, W. Landuyt, A.T. van Oosterom

Journal:

European Journal of Cancer

Year:

2004

Language:

english

File:

PDF, 181 KB

english, 2004

61

International Society of Geriatric Oncology (SIOG) recommendations for the adjustment of dosing in elderly cancer patients with renal insufficiency

Stuart M. Lichtman, Hans Wildiers, Vincent Launay-Vacher, Christopher Steer, Etienne Chatelut, Matti Aapro

Journal:

European Journal of Cancer

Year:

2007

Language:

english

File:

PDF, 285 KB

english, 2007

62

EORTC elderly task force position paper: Approach to the older cancer patient

A.G. Pallis, C. Fortpied, U. Wedding, M.C. Van Nes, B. Penninckx, A. Ring, D. Lacombe, S. Monfardini, P. Scalliet, H. Wildiers

Journal:

European Journal of Cancer

Year:

2010

Language:

english

File:

PDF, 190 KB

english, 2010

63

Questionnaires and instruments for a multidimensional assessment of the older cancer patient: What clinicians need to know?

A.G. Pallis, U. Wedding, D. Lacombe, P. Soubeyran, H. Wildiers

Journal:

European Journal of Cancer

Year:

2010

Language:

english

File:

PDF, 149 KB

english, 2010

64

Immediate versus delayed self-reporting of symptoms and side effects during chemotherapy: Does timing matter?

Annemarie Coolbrandt, Koen Van den Heede, Ellen Vanhove, Ann De Bom, Koen Milisen, Hans Wildiers

Journal:

European Journal of Oncology Nursing

Year:

2011

Language:

english

File:

PDF, 274 KB

english, 2011

65

Comprehensive geriatric assessment (CGA) in older oncological patients: Why and how?

Hans Wildiers, Cindy Kenis

Journal:

Journal of Geriatric Oncology

Year:

2012

Language:

english

File:

PDF, 183 KB

english, 2012

66

p16INK4a: A central player in cellular senescence and a promising aging biomarker in elderly cancer patients

Bert Vandenberk, Barbara Brouwers, Sigrid Hatse, Hans Wildiers

Journal:

Journal of Geriatric Oncology

Year:

2011

Language:

english

File:

PDF, 663 KB

english, 2011

67

Main priorities for the development of geriatric oncology: A worldwide expert perspective

Martine Extermann, Matti Aapro, Riccardo Audisio, Lodovico Balducci, Jean-Pierre Droz, Christopher Steer, Hans Wildiers, Gilbert Zulian

Journal:

Journal of Geriatric Oncology

Year:

2011

Language:

english

File:

PDF, 171 KB

english, 2011

68

114 POSTER Functional health status predicts 30 days postoperative outcome in elderly cancer patient

R. Hodigere Sripathy Jois, D.P. Pope, A. Stotter, H. Hoekstra, R. Gennari, M. Colledan, M. Maffezzini, F. Bozzetti, H. Wildiers, R. Audisio

Journal:

European Journal of Surgical Oncology (EJSO)

Year:

2006

Language:

english

File:

PDF, 64 KB

english, 2006

69

Treatment of operable breast cancer in the elderly: a randomised clinical trial EORTC 10851 comparing tamoxifen alone with modified radical mastectomy

I.S Fentiman, M.-R Christiaens, R Paridaens, A Van Geel, E Rutgers, J Berner, G de Keizer, J Wildiers, M Nagadowska, C Legrand, P Therasse

Journal:

European Journal of Cancer

Year:

2003

Language:

english

File:

PDF, 173 KB

english, 2003

70

Continuing chemotherapy or not after the induction treatment in advanced breast cancer patients: clinical outcomes and oncologists’ preferences

M.A Nooij, J.C.J.M de Haes, L.V.A.M Beex, J Wildiers, J Klijn, D Becquart, J Jassem, E Engelsman, L Duchateau

Journal:

European Journal of Cancer

Year:

2003

Language:

english

File:

PDF, 163 KB

english, 2003

71

3060 POSTER Renal Safety of Zoledronic Acid (ZOL) in Patients (pts) Starting ZOL Therapy and Beyond 2 Years of Treatment – a Prospective Multi-center Evaluation

T. Van den Wyngaert, M. Delforge, C. Doyen, L. Duck, I. Delabaye, H. Wildiers

Journal:

European Journal of Cancer

Year:

2011

Language:

english

File:

PDF, 42 KB

english, 2011

72

280 The Expression of RANTES (CCL5) is Inversely Correlated with Lymph Node Involvement in Breast Cancer

A. Smeets, B. Brouwers, S. Hatse, A. Belmans, A. Laenen, P. Neven, M.R. Christiaens, H. Wildiers

Journal:

European Journal of Cancer

Year:

2012

Language:

english

File:

PDF, 61 KB

english, 2012

73

336 Retrospective CYPTAM-BRUT 1 Study Shows Association Between the Genetic Variants Rs1800716 and Rs727479 in Tamoxifen Metabolisation and Tamoxifen-induced Increase in Double Endometrial Thickness

A.S. Dieudonne, D. Lambrechts, D. Smeets, A. Belmans, H. Wildiers, C. Hyonil, D. Timmerman, M.R. Christiaens, I. Vergote, P. Neven

Journal:

European Journal of Cancer

Year:

2012

Language:

english

File:

PDF, 58 KB

english, 2012

74

342 Prognostic Implications of Invasive Lobular Breast Cancer

O. Brouckaert, A. Laenen, H. Wildiers, K. Leunen, F. Amant, A. Smeets, E. Van Limbergen, G. Floris, M.R. Christiaens, P. Neven

Journal:

European Journal of Cancer

Year:

2012

Language:

english

File:

PDF, 58 KB

english, 2012

75

401 Prospective Assessment of Loss of Grip Strength by Baseline BMI in Breast Cancer Patients Receiving Adjuvant Aromatase Inhibitors or Tamoxifen

A. Lintermans, A.S. Dieudonne, J. Vanderhaegen, N.L. Henry, H. Wildiers, R. Paridaens, M.R. Christiaens, A. Smeets, K. Leunen, P. Neven

Journal:

European Journal of Cancer

Year:

2012

Language:

english

File:

PDF, 73 KB

english, 2012

76

415 Genetic Variability in Multi Drug Resistance Protein 1 (ABCC1/MRP1) and UDP-Glucuronosyltransferase-2B7 (UGT2B7) Are Highly Correlated with Severe Haematological Toxicity of Adjuvant FEC in Breast Cancer

C. Vulsteke, D. Lambrechts, A.S. Dieudonné, S. Hatse, B. Brouwers, T. Van Brussel, P. Neven, A. Belmans, R. Paridaens, H. Wildiers

Journal:

European Journal of Cancer

Year:

2012

Language:

english

File:

PDF, 62 KB

english, 2012

77

435 Genetic Variability in the Methylenetetrahydrofolate Reductase (NAD(P)H) Gene (MTHFR) is Associated with Severe Non Hematological Toxicity of Adjuvant FEC in Breast Cancer

C. Vulsteke, D. Lambrechts, A.S. Dieudonne, S. Hatse, B. Brouwers, T. Van Brussel, P. Neven, A. Belmans, R. Paridaens, H. Wildiers

Journal:

European Journal of Cancer

Year:

2012

Language:

english

File:

PDF, 74 KB

english, 2012

78

Locally advanced breast cancer (LABC): neoadjuvant chemotherapy with sequential doxorubicine (DOX) and docetaxel (DOC)

W. Wynendaele, R. Paridaens, J. Wildiers, M.R. Christiaens, W. Van den Bogaert, A.T. van Oosterom

Journal:

European Journal of Cancer

Year:

1999

Language:

english

File:

PDF, 159 KB

english, 1999

79

26 Towards Critical Evaluation of Patient Education on Chemotherapy – Development and Psychometric Evaluation of Two Instruments Measuring Knowledge and Self-care in Chemotherapy Patients

A. Coolbrandt, K. Van den Heede, C. Verslype, H. Wildiers, K. Milisen

Journal:

European Journal of Oncology Nursing

Year:

2012

Language:

english

File:

PDF, 52 KB

english, 2012

80

Management of breast cancer in elderly individuals: recommendations of the International Society of Geriatric Oncology

Hans Wildiers, Ian Kunkler, Laura Biganzoli, Jacques Fracheboud, George Vlastos, Chantal Bernard-Marty, Arti Hurria, Martine Extermann, Véronique Girre, Etienne Brain, Riccardo A Audisio, Harry Bartel

Journal:

The Lancet Oncology

Year:

2007

Language:

english

File:

PDF, 270 KB

english, 2007

81

Taxanes and anthracyclines in early breast cancer: which first?

Hans Wildiers, Kathleen Forceville, Robert Paridaens, Heikki Joensuu

Journal:

The Lancet Oncology

Year:

2010

Language:

english

File:

PDF, 76 KB

english, 2010

82

VEGF pathway genetic variants as biomarkers of treatment outcome with bevacizumab: an analysis of data from the AViTA and AVOREN randomised trials

Diether Lambrechts, Bart Claes, Paul Delmar, Joke Reumers, Massimiliano Mazzone, Betül T Yesilyurt, Roland Devlieger, Chris Verslype, Sabine Tejpar, Hans Wildiers, Sanne de Haas, Peter Carmeliet, Stef

Journal:

The Lancet Oncology

Year:

2012

Language:

english

File:

PDF, 803 KB

english, 2012

83

641 POSTER Effecacy and prediction of response to the new oral taxane DJ-927 in anthacycline pre-treated advanced breast cancer (ABC)

S. Chan, R. Paridaens, A. Awada, A. Mukherjee, P. Lawton, H. Dumez, H. Wildiers, C. Bernard, R. Oyama, A. Jenner

Journal:

European Journal of Cancer Supplements

Year:

2006

Language:

english

File:

PDF, 55 KB

english, 2006

84

Neoadjuvant capecitabine (X), docetaxel (T)±trastuzumab (H) for patients (pts) with locally advanced breast cancer (LABC): preliminary safety and efficacy data from a multicentre phase II study

W. Lybaert, Wildiers, P. Neven, P. Clement, M.R. Christiaens, C. Weltens, R. Drijkoningen, C. Van Ongeval, A. Van Steen, R. Paridaens

Journal:

European Journal of Cancer Supplements

Year:

2006

Language:

english

File:

PDF, 258 KB

english, 2006

85

Potential role of [18F]FDG-PET/CT in the evaluation of therapy response after neoadjuvant chemotherapy

I. Segaert, Neven, S. Stroobants, M. Drijkoningen, F. Amant, K. Leunen, H. Wildiers, A. Smeets, I. Vergote, M.R. Christiaens

Journal:

European Journal of Cancer Supplements

Year:

2006

Language:

english

File:

PDF, 116 KB

english, 2006

86

Implication of polysomy 17 in HER-2/neu overexpressing breast cancers

I. Vanden Bempt, De Wolf-Peeters, F. Amant, P. Neven, H. Wildiers, R. Paridaens, A. Smeets, M.R. Christiaens, E. Van Limbergen, M. Drijkoningen

Journal:

European Journal of Cancer Supplements

Year:

2006

Language:

english

File:

PDF, 269 KB

english, 2006

87

Chemotherapy dosing in elderly cancer patients – SIOG guidelines

Journal:

European Journal of Cancer Supplements

Year:

2007

Language:

english

File:

PDF, 52 KB

english, 2007

88

1132 POSTER A large multicenter prospective randomised trial on the treatment of death rattle in terminal care

H. Wildiers, C. D'haenekint, P. Clement, M. Desmet, P. Demeulenaere, R. van Nuffelen, E. van Droogenbroeck, F. Geurs, J.P. Lobelle, J. Menten

Journal:

European Journal of Cancer Supplements

Year:

2007

Language:

english

File:

PDF, 81 KB

english, 2007

89

1301 POSTER Surgical risk prediction with PACE (Preoperative Assessment of Cancer in the Elderly)

R.A. Audisio, H.S.J. Ramesh, D. Pope, M. Maffezzini, F. Bozzetti, M. Colledan, G. Corsini, H. Wildiers, R. Gennari, H.J.H.J. Hoekstra

Journal:

European Journal of Cancer Supplements

Year:

2007

Language:

english

File:

PDF, 57 KB

english, 2007

90

1300 POSTER Chemotherapy in elderly patients with renal Insufficiency. Recommendations of the International Society of Geriatric Oncology (SIOG)

S.M. Lichtman, H. Wildiers, V. Launay-Vacher, C. Steer, E. Chatelut, M. Aapro

Journal:

European Journal of Cancer Supplements

Year:

2007

Language:

english

File:

PDF, 57 KB

english, 2007

91

1303 POSTER Renal insufficiency in elderly cancer patients: International Society of Geriatric Oncology (SIOG) clinical practice recommendations.

V. Launay-Vacher, E. Chatelut, S.M. Lichtman, H. Wildiers, C. Steer, M. Aapro

Journal:

European Journal of Cancer Supplements

Year:

2007

Language:

english

File:

PDF, 59 KB

english, 2007

92

2083 POSTER Adjuvant delivery of a dose-dense, sequential FEC-docetaxel regimen to patients with high-risk breast cancer is feasible – results of a randomized, open-label Phase II study

H. Wildiers, L. Dirix, P. Neven, A. Prové, P. Clement, F. Amant, R. Paridaens

Journal:

European Journal of Cancer Supplements

Year:

2007

Language:

english

File:

PDF, 61 KB

english, 2007

93

2054 POSTER Acute effects on cardiac function after breast radiotherapy – a strain rate imaging study

K. Erven, R. Jurcut, C. Weltens, H. Wildiers, J. D'Hooge, J.U. Voigt, W. van den Bogaert

Journal:

European Journal of Cancer Supplements

Year:

2007

Language:

english

File:

PDF, 60 KB

english, 2007

94

Expression profiling of cancerous and normal breast tissues identifies microRNAs that are differentially expressed in serum from patients with (metastatic) breast cancer and healthy volunteers

Eleni van Schooneveld, Maartje CA Wouters, Ilse Van der Auwera, Dieter J Peeters, Hans Wildiers, Peter A Van Dam, Ignace Vergote, Peter B Vermeulen, Luc Y Dirix, Steven J Van Laere

Journal:

Breast Cancer Research

Year:

2012

Language:

english

File:

PDF, 887 KB

english, 2012

95

“Classical” CMF versus a 3-weekly intravenous CMF schedule in postmenopausal patients with advanced breast cancer: An EORTC Breast Cancer Co-operative Group Phase III Trial (10808)

E. Engelsman, J.C.M. Klijn, R.D. Rubens, J. Wildiers, L.V.A.M. Beex, M.A. Nooij, N. Rotmensz, R. Sylvester

Journal:

European Journal of Cancer and Clinical Oncology

Year:

1991

Language:

english

File:

PDF, 543 KB

english, 1991

96

A call for observational cohort studies in geriatric oncology

Supriya Gupta Mohile, Hans Wildiers

Journal:

Journal of Geriatric Oncology

Year:

2012

Language:

english

File:

PDF, 189 KB

english, 2012

97

The oestrogen receptor interacts with the correlation between HER-2 over-expression and age at diagnosis, tumour grade and lymph node involvement in operable breast cancers: a single centre experience

P. Neven, V. Van Belle, I. Vanden Bempt, K. Deraedt, P. Moerman, R. Paridaens, K. Leunen, A. Smeets, H. Wildiers, M.R. Christiaens

Journal:

European Journal of Cancer Supplements

Year:

2008

Language:

english

File:

PDF, 71 KB

english, 2008

98

Clinicopathological features of inflammatory versus noninflammatory locally advanced non-metastatic breast cancer

B. Brouwers, R. Paridaens, J.P. Lobelle, W. Hendrickx, A. Smeets, P. Neven, C. Weltens, K. Deraedt, I. Vanden Bempt, H. Wildiers

Journal:

European Journal of Cancer Supplements

Year:

2008

Language:

english

File:

PDF, 57 KB

english, 2008

99

External validation of a piecewise effect model of axillary lymph node involvement in elderly breast cancer patients

H. Wildiers, B. Van Calster, L.V. van de Poll-Franse, W. Hendrickx, S. Van Huffel, A. Smeets, R. Paridaens, K. Deraedt, M.R. Christiaens, P. Neven

Journal:

European Journal of Cancer Supplements

Year:

2008

Language:

english

File:

PDF, 58 KB

english, 2008

100

130 Breast cancer in the elderly: a medical perspective

Journal:

European Journal of Cancer Supplements

Year:

2009

Language:

english

File:

PDF, 45 KB

english, 2009